Source: Annual Congress 2007 - New drugs for asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Phillips, M. Bennetts, K. Banner, J. Ward, D. Wessels, R. Fuhr (Sandwich, London, United Kingdom; Berlin, Germany). The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine. Eur Respir J 2007; 30: Suppl. 51, 2964

Member's Comments

No comment yet.

Related content which might interest you: The inhaled PDE4 inhibitor GSK256066 significantly inhibits airway responses following allergen challenge in asthmatics Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008 Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009 The different effect of NO-synthase inhibitors in allergen and toluene-induced airway hyperreactivity Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity Source: Eur Respir J 2005; 25: 864-872 Year: 2005 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003 Airway hyperresponsiveness in children Source: Eur Respir Mon 2012; 56: 158-171 Year: 2012 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013 Interleukin-17 in induced sputum correlates with airway hyperresponsiveness to methacholine Source: Eur Respir J 2001; 18: Suppl. 33, 193s Year: 2001 Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003